SRPT logo

SRPT
Sarepta Therapeutics Inc

26,711
Mkt Cap
$2.28B
Volume
2.01M
52W High
$129.84
52W Low
$10.42
PE Ratio
-7.44
SRPT Fundamentals
Price
$21.53
Prev Close
$21.75
Open
$21.72
50D MA
$20.97
Beta
1.08
Avg. Volume
6.23M
EPS (Annual)
$2.34
P/B
1.71
Rev/Employee
$1.39M
Loading...
Loading...
News
all
press releases
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Down - Here's What Happened
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Down - Time to Sell...
MarketBeat·13h ago
News Placeholder
More News
News Placeholder
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Down - What's Next?
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Down - Should You Sell...
MarketBeat·13h ago
News Placeholder
Why Is SRPT Stock Falling Today?
Sarepta Therapeutics announced a debt refinancing plan totaling about $291 million.
Stocktwits·2d ago
News Placeholder
Sarepta Therapeutics Announces Refinancing of Approximately $291 Million of 1.25% Convertible Senior Notes due 2027
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has entered into separate, privately negotiated exchange agreements with...
Business Wire·2d ago
News Placeholder
Sarepta Therapeutics, Inc. $SRPT Shares Bought by Federated Hermes Inc.
Federated Hermes Inc. grew its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 347.8% during the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·3d ago
News Placeholder
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Up - What's Next?
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Up - What's Next...
MarketBeat·4d ago
News Placeholder
Sarepta Therapeutics (NASDAQ:SRPT) Coverage Initiated by Analysts at Wedbush
Wedbush began coverage on Sarepta Therapeutics in a research report on Tuesday. They issued an "outperform" rating and a $32.00 price target for the company...
MarketBeat·4d ago
News Placeholder
New York State Common Retirement Fund Sells 7,923,000 Shares of Sarepta Therapeutics, Inc. $SRPT
New York State Common Retirement Fund cut its stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 98.4% in the 2nd quarter, according to the company in its most recent disclosure with...
MarketBeat·4d ago
News Placeholder
Norges Bank Buys Shares of 913,407 Sarepta Therapeutics, Inc. $SRPT
Norges Bank purchased a new position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities...
MarketBeat·4d ago
News Placeholder
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Down - Time to Sell?
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Down - Here's Why...
MarketBeat·9d ago

Latest SRPT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.